POINT Biopharma Global Inc.
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand …
Biotechnology
US, Indianapolis [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared POINT Biopharma Global Inc. (PNT) to it's peer group.
Peer Group
CERE RVMD IMTX CRNX AVTE CYT ORIC ENOB HLVX PMVP EWTX STRO INBX RAPT ALXO BCAB THRD LYRA PRDS
Compare Together
Loading...